ABOUT: The board of directors of Midas Incorporated - symbol MDS - is Reviewing Strategic and financial alternatives for the company which may include, but are not limited to, a possible sale, merger or other business combination. According to its Unaudited Second Quarter 2011 Financial Results, the Sales of Sinovac Biotech limited - symbol SVA - increased 52.5% year-over-year to $15.7 million. Sinovac has obtained the GMP certificate for its seasonal flu vaccine and hepatitis A vaccine from the Federal Commission for the Protection Against Sanitary Risk of Mexico Ministry of Health. MannKind Corporation - symbol MNKD - has confirmed with the U.S. Food and Drug Administration the design of two clinical studies that evaluate the efficacy and safety of AFREZZA. AFREZZA is a novel, ultra rapid acting mealtime insulin therapy being developed by MannKind Corporation for the treatment of adult patients with type 1 or type 2 diabetes for the control of hyperglycemia (high blood glucose).